Clinical Trials Sponsored by Peking University Eye Center

Total 742 results

Peking University Cancer Hospital & Institute

Recruiting

Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for AGC

Laparoscopic Surgery | Gastric Cancer | Gastrectomy | Lymphadenectomy

China
Peking University Cancer Hospital & Institute

Completed

Preliminary Study on Eye Features of Patients With Malignant Tumors

Cancer Patients | Feature Elongation

China
Peking University Cancer Hospital & Institute

Completed

The Study of KN046 in Combination With Lenvatinib in Advanced Hepatocellular Carcinoma

HCC

China
Peking University Cancer Hospital & Institute

Active, not recruiting

RSYR for Fatigue Reduction in Cancer Fatigue Caused by Chemotherapy (TCM)

Cancer-related Problem/Condition

China
Peking University Cancer Hospital & Institute

Completed

Abscopal Effect of Radiation in Combination With rhGM-CSF for Metastatic Non-small Cell Lung Cancer

Lung Cancer Metastatic

China
Peking University Cancer Hospital & Institute

Completed

Different Radiation Dose With Concurrent Chemotherapy for Thoracic Esophageal Carcinoma

Esophageal Cancer

China
Peking University Cancer Hospital & Institute

Completed

Tailored Operative or Non-operative Management for Low-risk Rectal Cancer After Intensive Neoadjuvant Treatment

Rectal Cancer

China
Peking University Cancer Hospital & Institute

Unknown

Early Diagnosis of Therapy-associated Cardiotoxicity Basing on Multi-tracer Multimodality PET/MRI

Magnetic Resonance Imaging | Positron-Emission Tomography

China
Peking University Cancer Hospital & Institute

Unknown

TACE Plus HAIC With Oxaliplatin and Raltitrexed for BCLC Stage C HCC (OXRI)

Hepatocellular Carcinoma | Transarterial Chemoembolization
Peking University Cancer Hospital & Institute

Unknown

Camrelizumab Plus Apatinib and Temozolomide as First Line Therapy in Advanced Acral Melanoma

Melanoma
Peking University Cancer Hospital & Institute

Unknown

Drug Sensitivity Screening for Gastrointestinal Cancer

Gastrointestinal Cancer Metastatic

China
Peking University Cancer Hospital & Institute

Unknown

PD-1 Antibody SHR-1210 Combined With Apatinib of First-line Treatment of Advanced Acral Melanoma

Melanoma

China
Peking University Cancer Hospital & Institute

Completed

RSYR for Fatigue Reduction in Cancer Survivors

Cancer-related Problem/Condition
Peking University Cancer Hospital & Institute

Unknown

Comparison Between Double Tract Anastomosis and Esophagogastrostomy After Radical Proximal Gastrectomy

Gastric Cancer | GastroEsophageal Cancer
Peking University Cancer Hospital & Institute

Unknown

The Effect of Percutaneous Radiofrequency Ablation of Feeding Arterial for Hepatocellular Carcinoma

Liver Neoplasms

China
Peking University Cancer Hospital & Institute

Unknown

Endoscopic Ultrasound in Detailed T-staging of Upper GI Malignancies in Vitro

Gastrointestinal Neoplasms

China
Peking University Cancer Hospital & Institute

Unknown

Rh-endostatin in Combination With Dacarbazine and Cisplatin as the First Line Therapy for Metastatic Melanoma

Melanoma

China
Peking University Cancer Hospital & Institute

Unknown

18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Diffuse Large B-cell Lymphoma

Lymphoma, Large B-Cell, Diffuse

China
Peking University Cancer Hospital & Institute

Unknown

A Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in Refractory Metastatic GIST

Gastrointestinal Stromal Tumor

China
Peking University Cancer Hospital & Institute

Completed

Potential Role for Carbon Nanoparticles to Guide Central Neck Dissection in Patients With Papillary Thyroid Cancer

Thyroid Cancer
Peking University Cancer Hospital & Institute

Completed

Gene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural Effusion (GMPE)

Breast Neoplasms | Neoplasm Metastasis | Immunotherapy | Gene Expression Profiling

China
Peking University Cancer Hospital & Institute

Unknown

Safety Study of Combining Ultrasound Microbubbles and Chemotherapy to Treat Malignant Neoplasms of Digestive System

Gastrointestinal Neoplasms

China
Peking University Cancer Hospital & Institute

Completed

Study of Chemotherapy With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients (DCCIK)

Breast Neoplasms | Neoplasm Metastasis

China
Peking University Cancer Hospital & Institute

Unknown

A Phase II Study of Imatinib Versus Interferon as Adjuvant Therapy in KIT-mutated Melanoma

Melanoma

China
Singapore National Eye Centre
National University, Singapore

Completed

Assessment of Fibrin Glue in Pterygium Surgery and Other Forms of External Eye Surgery

Pterygium | Ocular Surface Cicatrizing Diseases

Singapore
Peking University Cancer Hospital & Institute

Recruiting

A Study of LUCAR-20SP in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

China
Peking University Cancer Hospital & Institute

Recruiting

KN046 Plus Regorafenib or Apatinib in MSI-H Digestive System Cancers Resistant to PD-1/PD-L1 Blockade

Digestive System Cancers

China
Peking University Cancer Hospital & Institute

Recruiting

Palbociclib Combine With Anti-HER2 Therapy in Triple Positive ABC

Breast Neoplasm Female

China
Peking University Cancer Hospital & Institute

Recruiting

the Beijing Randomized Study Of Prostate Cancer Screening (BROPCS)

Prostate Cancer

China
Peking University Cancer Hospital & Institute

Not yet recruiting

Clinical Study on the Efficacy and Safety of RC48-ADC in the Treatment of Metastatic Castration Resistant Prostate Cancer (mCRPC)

Metastatic Castration-resistant Prostate Cancer
Peking University Cancer Hospital & Institute

Recruiting

Molecular Subtyping of Extensive Stage Small Cell Lung Cancer and Relevent Clinical Significance (MOSAIC)

SCLC,Extensive Stage

China
Peking University Cancer Hospital & Institute

Recruiting

Phase 2 Study of SBRT Plus Tislelizumab and Regorafenib in Unresectable or Oligometastatic HCC

Unresectable Hepatocellular Carcinoma | Oligometastatic Disease

China
Peking University Cancer Hospital & Institute

Recruiting

PD-L2 Targeting Nanobody Radiotracer for PET Imaging of Solid Tumor

Colorectal Cancer | Lung Cancer

China
Peking University Cancer Hospital & Institute

Recruiting

Tislelizumab Consolidation Therapy After Radiotherapy or Sequential Chemoradiation in Locally Advanced NSCLC Patients

Non-small Cell Lung Cancer | Consolidation Immunotherapy | Radiotherapy or Sequential Chemoradiation

China
Peking University Cancer Hospital & Institute

Not yet recruiting

Outcomes of Endoscopic Operation in COVID-19 Infection: Cohort Study.

COVID-19 | Surgery-Complications

China
Peking University Cancer Hospital & Institute

Not yet recruiting

Cadonilimab in the Treatment of Advanced Soft Tissue Sarcoma

Soft Tissue Sarcoma
Peking University Cancer Hospital & Institute

Not yet recruiting

Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy for HR +/HER2 + Advanced Breast Cancer

Breast Neoplasm Female
Peking University Cancer Hospital & Institute

Recruiting

Evaluate the Safety and Tolerability of JCXH-212 Monotherapy and Combined With Toripalimab in the Treatment of Malignant Solid Tumors

Malignant Solid Tumors

China
Peking University Cancer Hospital & Institute

Recruiting

Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma

Melanoma | Temozolomide | Apatinib | Camrelizumab | Acral Melanoma | Neoadjuvant | Pathological Response

China
Peking University Cancer Hospital & Institute

Not yet recruiting

Nectin-4 Targeting ADC Probe for PET Imaging in Solid Tumors

Solid Tumor
Peking University Cancer Hospital & Institute

Recruiting

Imatinib and Toripalimab in Patients With Locally Advanced/Metastatic Melanoma Harbored With CKIT Mut

Advanced Melanoma

China
Peking University Cancer Hospital & Institute

Recruiting

PD-L1 Targeting Nanobody Probe for PET Imaging of Solid Tumor

Melanoma | Lung Cancer | PD-L1 | PET/CT

China
Peking University Cancer Hospital & Institute

Not yet recruiting

Study of Oncolytic Virus in Combination With HX-008 and Axitinib in Melanoma Patients With Liver Metastasis

Melanoma Stage IV
Peking University Cancer Hospital & Institute

Recruiting

To Explore the Efficacy and Safety of Camrelizumab Combined With SHR1020 in the Treatment of Advanced Melanoma

Melanoma

China
Peking University Cancer Hospital & Institute

Recruiting

Positron Nuclide Labeled DOTA-FAPI PET Study in Colocrectal Cancer

Colorectal Cancer | Positron-Emission Tomography | Tumor, Solid

China
Peking University Cancer Hospital & Institute

Recruiting

The Role of TCM on ERAS of Rectal Cancer Patients (RCT)

Rectal Cancer

China
Peking University Cancer Hospital & Institute

Not yet recruiting

To Identify KRAS Gene and Safe Margin in Association With Outcome in Colorectal Liver Metastases Following Ultrasound-guided Radiofrequency Ablation

Colorectal Cancer | Radiofrequency Ablation | Liver Metastasis | KRAS Gene | Safe Margin
Peking University Cancer Hospital & Institute

Recruiting

Total Neoadjuvant Therapy Followed by 'Watch and Wait' Approach or Organ Preservation for Low-risk Rectal Cancer (BJCC-R01)

Rectum Cancer

China
Peking University Cancer Hospital & Institute

Recruiting

Study to Evaluate OrienX010 in Combination With JS001 in the Treatment of Stage IV (M1c) Liver Metastasis From Melanoma

Melanoma

China
Peking University Cancer Hospital & Institute

Recruiting

Toripalimab in Combination With Axitinib in Patients With Localized Mucosal Melanoma

Mucosal Melanoma

China

Clinical Trials Sponsored by Peking University Eye Center

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Macedonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations